Inventor · disambiguated record
Todd Juan
Also filed as: JUAN TODD
8 granted patents·4 pending applications·9 citations·filing 2002–2025
79Inventor score
Top patents by PatentIndex Score
12 records- 0185US7981605B2Epidermal growth factor receptor mutationsAMGEN INC·Filed 2006·Granted Jul 19, 2011·7 cites·2 claims
- 0268US11155876B2K-ras mutations and anti-EGFr antibody therapyAMGEN INC·Filed 2018·Granted Oct 26, 2021·0 cites·1 claims
- 0366US2008293055A1K-ras mutations and anti-EGFr antibody therapyFREEMAN DANIEL·Filed 2008·Application pending·0 cites
- 0465US8546107B2Epidermal growth factor receptor mutationsFREEMAN DANIEL J·Filed 2011·Granted Oct 1, 2013·1 cites·7 claims
- 0564US10030270B2K-ras mutations and anti-EGFr antibody therapyFREEMAN DANIEL·Filed 2012·Granted Jul 24, 2018·0 cites·3 claims
- 0662US7771965B2Tumor endothelial marker 5α molecules and uses thereofAMGEN INC·Filed 2002·Granted Aug 10, 2010·1 cites·12 claims
- 0755US2009053763A1Tumor endothelial marker 7-alpha molecules and uses thereofAMGEN INC·Filed 2008·Application pending·0 cites
- 0852US8420332B2Tumor endothelial marker 5-α molecules and uses thereofJUAN TODD·Filed 2012·Granted Apr 16, 2013·0 cites·7 claims
- 0952US2025361473A1Cell culture structure and cell culture deviceBEYOND MFT INC·Filed 2025·Application pending·0 cites
- 1050US8071372B2Tumor endothelial marker 5α molecules and uses thereofJUAN TODD·Filed 2010·Granted Dec 6, 2011·0 cites·11 claims
- 1148US8163878B2Tumor Endothelial Marker 5-α molecules and uses thereofJUAN TODD·Filed 2010·Granted Apr 24, 2012·0 cites·7 claims
- 1245US2003092025A1Tumore endothelial market 7alpha molecules and uses thereofAMGEN INC A CORP OF THE STATE·Filed 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Todd Juan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →